Signal Point Hematology/Oncology is a clinical research site located in Middletown, Ohio, United States 45042.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Signal Point Hematology/Oncology has participated in 2 clinical trials.
Therapeutic areas: Colorectal Cancer, Non-Hodgkins Lymphoma.
Sponsors: HiberCell, Inc., Celgene.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Signal Point Hematology/Oncology has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Signal Point Hematology/Oncology has 2 clinical trials on record. Their work covers Colorectal Cancer, Non-Hodgkins Lymphoma.
Signal Point Hematology/Oncology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.